CEO: Sérgio Simões
Developing a photodynamic (light-based) therapy effective against primary tumors and metastasis.
CEO: Diogo Remechido Anjos
Developing a new technology platform, targeting cancer and chronic viral infections, called DOT cells, which do not attack healthy cells and quickly react to bad ones.
Developing nanotech-based, fully in-vitro molecular devices for point-of-care diagnosis or bacterial infections. Initial focus on the veterinary market.
CEO: Rui Oliveira
Focusing on Cell culture media formulation methods for the BioPharma industry to significantly enhance the yields of culture media.
CEO: João Pedro Ribeiro
PeekMed is a software solution developed for orthopedic surgeons, aims to optimize the pre-operative planning process. By simulating the expected results prior to the surgery occurring, it allows for more accuracy in the actual surgery.
CEO: João Barreto
Developing and manufacturing computer vision solutions for medical endoscopy. RDFixer is a visualisation system, the first of its kind on the market, that improves depth perception by removing the image distortion in real-time when performing Minimally Invasive Surgery.
Developing and manufacturing the next generation of silicon-based photomultipliers for Positron Emission Tomography.
CEO: Filipe Aguiar
Developing innovative functional excipients for application in the pharmaceutical and cosmetics industry, increasing efficiency, hence increasing production capacity via throughput.
Rui Amandi de Sousa
Develops medical devices and advanced therapies for regenerative medicine applications based on proprietary biomaterial platforms and tissue engineering.
CEO: Richard Hampson
Discovering and developing new generation drug candidates, at less than 10% of the industry's average cost. Its technological platform enables customisation to other targets related to carcinoma.